image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
70ca4017de011a93ee2ccf5e9c70e52e6f6ac8c0073c2e5baf76c3ea7897ff9d.png | simple | <table><tr><td></td><td>All patients<i>N</i>= 14</td><td>Survivors<i>n</i>= 7</td><td>Nonsurvivors<i>n</i>= 7</td><td><i>P</i>value</td></tr><tr><td>Characteristics at ICU admission</td><td></td><td></td><td></td><td></td></tr><tr><td> Age</td><td>32 (22–51)</td><td>23 (21–44)</td><td>48 (30–58)</td><... |
666738745146b41cb8e579e2d31130299bca66ed717e46b4e730c78926cd712e.png | complex | <table><tr><td></td><td colspan="2">Sham-vehicle (pg/mL)</td><td colspan="2">Sham-EFX (pg/mL)</td><td colspan="2">TBI-vehicle (pg/mL)</td><td colspan="2">TBI-EFX (pg/mL)</td><td>TBI-vehicle vs. TBI-EFX</td></tr><tr><td></td><td>Ipsilateral</td><td>Contralateral</td><td>Ipsilateral</td><td>Contralateral</td><td>Ipsilate... |
6c8d37e7e4fd59887a0ee55868466c7ec84f4ab9fd67b607ce05921755b255b6.png | simple | <table><tr><td></td><td></td><td>Enrichment score<sup>+</sup></td><td>Protein count (%)</td><td>Protein ID</td><td>P value</td></tr><tr><td>Biological process</td><td>Regulation of response to external stimulus</td><td>2.3</td><td>3 (27.27)</td><td>AHSG, C3, HRG</td><td>4.69e-3</td></tr><tr><td></td><td>Cellular iron i... |
d8f308e2f0a414e5569cfb21b6018be948f75df541aebaa952800a95b3a4278b.png | complex | <table><tr><td> </td><td> </td><td colspan="4">Assessment</td></tr><tr><td>Outcomes</td><td>Measures</td><td>t1</td><td>t2</td><td>t3</td><td>t4</td></tr><tr><td rowspan="2">Self-management competence (primary outcome)</td><td>Health education impact questionnaire heiQ, German version [29]. Subscales Self-monitoring an... |
680ca7816f8d4e6cd4064f17c21f45ccbedd9b8af99d9838740a5cd353d040c0.png | complex | <table><tr><td rowspan="2">Year of birth</td><td colspan="6">DHS</td><td colspan="2">Masakacohort</td><td colspan="2">Rakaicohort</td></tr><tr><td>1988</td><td>1995</td><td>2001</td><td>2006</td><td>Total</td><td>Median AFS†</td><td>N</td><td>Median AFS</td><td>N</td><td>Median AFS</td></tr><tr><td>1950–9</... |
29cb3f0e7893ab597aab46561e0a05f25f82bce5d17d1d6f0d75ce0198bba48c.png | simple | <table><tr><td></td><td>Hypermethylated</td><td>Hypomethylated</td></tr><tr><td>n</td><td>3925</td><td>4615</td></tr><tr><td>CpG island location</td><td>CpG islands</td><td>Non-CGI</td></tr><tr><td>Genomic location</td><td>TSS, 1st exon</td><td>Gene body, outside genes</td></tr><tr><td>Associated genes</td><td>1832</td... |
8d95d0c0471e62d68655ba12f515a815168f5b585c33d726f602a45f72f056db.png | complex | <table><tr><td></td><td>DNA binding consensus sequence</td><td>Putative binding site found in putative ATRX promoter</td><td>Biological roles</td><td>References</td></tr><tr><td colspan="5">5'UTR of ATRX (+215 to +1)</td></tr><tr><td>YY1(+38 to +29)</td><td>SNCCATNTT</td><td>CGCCATTTT</td><td>Activator/repressor involv... |
60d546ab259643f76441db8ae7c96804217c80fd0354e60c647ba91efccd1cab.png | complex | <table><tr><td rowspan="2">Titer of serum from one sheep infected intrapulmonarily with 300.000 TCID 50 of virus K796</td><td colspan="3">Virus strains</td></tr><tr><td>K796</td><td>10B</td><td>7W</td></tr><tr><td>Serum 13 months after infection with K796</td><td>128</td><td>16</td><td>8</td></tr><tr><td>Serum 3 years ... |
46bd3b3d1179ae47f818c27abd6961b5fb77410a4c706727c1291fe9d91e653a.png | simple | <table><tr><td>Gene ID</td><td>Gene Product Description</td><td>Hilltop</td><td>Valley bottom</td></tr><tr><td>PF3D7_1121600</td><td>circumsporozoite-related antigen (CRA)</td><td>0.12 (0.05 - 0.19)</td><td>0.51 (0.39 - 0.63)</td></tr><tr><td>PF3D7_1035700</td><td>duffy binding-like merozoite surface protein (DBLMSP)</... |
1531e52aadba335356f2ec49cfd195a538d76e5f25a9997b5597889b06cc83ea.png | simple | <table><tr><td>Traits/Disease</td><td>No. of Putative Associations</td></tr><tr><td>Conduct disorder (case status) *</td><td>11</td></tr><tr><td>Ischemic stroke</td><td>11</td></tr><tr><td>Atrial fibrillation/atrial flutter*</td><td>10</td></tr><tr><td>Permanent tooth development*</td><td>10</td></tr><tr><td>Conduct di... |
22efd72395de644cf100ff1a0dbfa575c856e2af7df2bceecf1c4b4ba3023eaf.png | complex | <table><tr><td rowspan="2">Sentence duration</td><td rowspan="2"><i>N</i></td><td colspan="2">Plaque index</td><td colspan="2">Tartar index</td><td colspan="2">Total OHI</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Till 1 year</td><td>68</td><td>1.56</td><td>0.76</td... |
7a02b87600372d452fb70e72400d87c31ecbb664f0bd45cb8e87454b6f9cb32c.png | simple | <table><tr><td>HbB Genotype</td><td>Numbers (87)<sup>a</sup></td><td>G6PD Genotype</td><td>Numbers (84)<sup>a</sup></td><td>68 Status</td><td>126 Status</td><td>Deduced Phenotype<sup>b</sup></td></tr><tr><td></td><td></td><td>68–126</td><td></td><td></td><td></td><td></td></tr><tr><td>AA</td><td>75 (86%)</td><td>... |
72c3d3f23844c468353ff726066aa1d0bf12c44d4f8d93ff22e69db51ac36de0.png | complex | <table><tr><td>Age</td><td colspan="2">65 – 74</td><td colspan="2">75 – 84</td><td colspan="2">≥ 85</td></tr><tr><td>Vaccinated</td><td>yes</td><td>no</td><td>yes</td><td>no</td><td>yes</td><td>no</td></tr><tr><td><i>2003 Influenza season</i></td><td></td><td></td><td></td><td></td><td></td><td></td><... |
cd332a328ebdac0e2197f1bd9776fbc57be1e0ef2f653bc89e87cde77cb4f3c9.png | simple | <table><tr><td>Variable</td><td>% increase (95% CI)</td></tr><tr><td>Age</td><td></td></tr><tr><td> 35-64 years</td><td>1.48 (0.28, 2.70)</td></tr><tr><td> 65-74 years</td><td>1.54 (0.34, 2.75)</td></tr><tr><td> 75-84 years</td><td>1.59 (0.42, 2.77)</td></tr><tr><td> ≥ 85 years</td><td>1.51 (0.34, 2.70)</td></tr>... |
ad5f8183b1ac32738703b578b8fff6741e6e9e9d4f5dc5967c4b9a6280d32705.png | complex | <table><tr><td></td><td colspan="2">Rape NOS</td><td colspan="2">Gang Rape</td><td colspan="2">Sexual Slavery</td><td colspan="2">Combined Gang Rape and Sexual Slavery</td></tr><tr><td></td><td>Number</td><td>Percent</td><td>Number</td><td>Percent</td><td>Number</td><td>Percent</td><td>Number</td><td>Percent</td></tr><... |
02389faf3f2800c41f920a8b3f5862a011931c0ea004bfa7f27d0e26a3bf7b64.png | complex | <table><tr><td></td><td>Key inclusion and exclusion criteria</td><td>Orchard et al. [7]</td><td>Meisser et al. [8]</td><td>Noehren et al. [11]</td><td>Ferber et al. [12]</td><td>Phinyonmark et al. [20]</td><td>Foch et al. [21]</td><td>Foch and Milner [22]</td><td>Foch and Milner [23]</td><td>Grau et al. [24]</td><td>He... |
d1bacf47b5f53c2861d5a75d0a737c253c9ef6342a74f5875da7881161cd6d52.png | simple | <table><tr><td></td><td>Ordinary light</td><td>Infrared ray light</td></tr><tr><td>ICG-positive nodedetection</td><td>28/36(78 %)</td><td>36/36</td></tr><tr><td>The number ofICG-positive nodes</td><td>3.4 ± 3.7<sup>*</sup>(0 to 16)<sup>+</sup></td><td>9.2 ± 5.9<sup>*</sup>(2 to 25)<sup>+</sup></td></tr><tr><t... |
0112b07d4ec58c9cb0e008539ed6735f70516ecde9aa55cd8acb77a9d35a77ee.png | simple | <table><tr><td>Test </td><td>Day 0 (admission)</td><td>Day 13 (discharge)</td></tr><tr><td>Coxsackie A9 (NT)</td><td>8 Units</td><td>16 Units</td></tr><tr><td>Coxsackie B1 (NT)</td><td>16 Units</td><td>32 Units</td></tr><tr><td>Coxsackie B2 (NT)</td><td><4 Units</td><td><4 Units</td></tr><tr><td>Coxsackie B3 (NT)... |
d68608421770de82f33270098e5b2cf565a929663bebf4f2380af90daf358489.png | simple | <table><tr><td>Characteristic</td><td>Female</td><td>Male</td><td>Total</td></tr><tr><td><i>n</i> of subjects</td><td>14</td><td>14</td><td>28</td></tr><tr><td>Gender (M/F) %</td><td></td><td></td><td>50/50</td></tr><tr><td>Age (years)</td><td>23 (23, 23)</td><td>20.5 (19, 21.25)</td><td>21.75 ± 1.92</td></tr><tr>... |
65ff95bf8cbc342d2632aa3a4c3076067c22bccf0948906307399fd6db975fe7.png | simple | <table><tr><td>Who Would Use the App?</td><td>When Would They Use the App?</td><td>How Useful Is an App?</td><td>What Should Be in the App?</td><td>Who or How Should It Be Advertised to Users?</td></tr><tr><td>Parents of children ages 0–6First time momsParents about to switch their child to a new seatCaregiversFa... |
3f49f2b60a45e61ddf45c95fdf54a680c4e63a5ae7d79a53ba290e027077453b.png | simple | <table><tr><td>Organizational</td><td>Socio-cultural</td><td>Intrinsic</td></tr><tr><td><i>Motivators</i></td><td></td><td></td></tr><tr><td>• Opportunities for higher qualifications</td><td>• Respect</td><td>• Serving people</td></tr><tr><td>• Good working and hygienic conditions</td><td>•... |
481b4d7cf5ec36ca29c915ab69b0067b362a2fef5f5f25943a1deb99a25a2f7f.png | simple | <table><tr><td>Cost variable</td><td>Source</td><td>Unit cost in public system (Dollar)</td><td>Unit cost in private system (Dollar)</td></tr><tr><td>Medical visit</td><td></td><td></td><td></td></tr><tr><td>Public</td><td>Hospital accounts department/DMA</td><td>5*</td><td>125 (range 100-150)</td></tr><tr><td>Medicati... |
2d87ae17623d10c7cf796815f212d7d84eadaae4494702aa671659eec1f0e0df.png | simple | <table><tr><td>Neuroprotectant</td><td>n (%*)</td></tr><tr><td>Edaravone</td><td>95 (8.4)</td></tr><tr><td>Ganglioside GM1</td><td>29 (2.6)</td></tr><tr><td>Cattle encephalon glycoside and ignotin</td><td>112 (9.9)</td></tr><tr><td>Cinepazide</td><td>56 (5.0)</td></tr><tr><td>Citicholine</td><td>334 (29.6)</td></tr><tr... |
9610eac5f7295e6cb655de4609a66430759e783d926ce33df6ff93fe1ffe876f.png | complex | <table><tr><td>Self-rated spiritual health</td><td>Ideators (%)</td><td>Non-ideators (%)</td><td><i>χ</i><sup>2</sup></td><td><i>p</i>-Value</td></tr><tr><td>Excellent OR good</td><td>117 (49.37)</td><td>2713 (85.10)</td><td rowspan="2">196.23</td><td rowspan="2"><.0001</td></tr><tr><td>Fair OR poor OR uncertai... |
6ee9726e541f7bc7ba8471f9dcb965b61850fb5541170101bc129c29b8ff38a8.png | simple | <table><tr><td>Variable</td><td>Controls (n = 73)</td><td>Participants (n = 73)</td><td>p value<sup>a</sup></td></tr><tr><td>Lipoprotein subclass<sup>b</sup></td><td></td><td></td><td></td></tr><tr><td>VLDL and chylomicron particle concentrations (nmol/L)</td><td></td><td></td><td></td></tr><tr><td> Total VLDL and chyl... |
cd916fbd1c5f9a653b4efdb9bab51229818616c91466497e0a9a973d01defc4c.png | simple | <table><tr><td></td><td>Regular expression method</td><td></td><td>Term voting method</td><td></td></tr><tr><td>TOTAL terms</td><td>98435</td><td>100%</td><td>98435</td><td>100%</td></tr><tr><td>Selected set</td><td>13755</td><td>14%</td><td>13755</td><td>14%</td></tr><tr><td>Excluded set</td><td>84680</td><td>86%</td>... |
3ef63dbfe1d3e88eca86c19b4ed4660f3a4007ae9c425f47256d7c84753f5e43.png | simple | <table><tr><td>N = 301</td><td>Total</td><td>Emotional</td><td>Physical</td><td>Active Coping</td><td>Passive Coping</td></tr><tr><td>Range</td><td>47.19</td><td>44.85</td><td>49.89</td><td>49.08</td><td>47.95</td></tr><tr><td>Minimum</td><td>26.63</td><td>31.07</td><td>20.44</td><td>25.04</td><td>24.91</td></tr><tr><t... |
278856d667f0495455f35e2dceeb010a9ae168388d55ca97326dd638cb839ab6.png | simple | <table><tr><td>Target gene</td><td>Forward primer (5′ to 3′)</td><td>Reverse primer (5′ to 3′)</td><td>Source</td></tr><tr><td>Mad2</td><td>GAGTTCTTCTCATTCGGCATCA</td><td>CCAATCTTTCAGTTGTTCCACC</td><td>PrimerBank</td></tr><tr><td>Bub1</td><td>TGCTGCACAACTTGCGTCTAC</td><td>TCAACGCCCAACTCTGCCT</td... |
ae757a1c13a63ffa6422e9e17a07e19d453f204b7cb6718ec2a9ee3fa947c074.png | complex | <table><tr><td colspan="2">Comparison</td><td>BC1 <i>vs </i>BC2</td><td>BC1 <i>vs </i>BC3</td><td>BC2 <i>vs </i>BC3</td></tr><tr><td>Successful Calls for Both</td><td>SNPs</td><td>134128046</td><td>134063768</td><td>134107787</td></tr><tr><td></td><td>%</td><td>99.241</td><td>99.194</td><td>99.226</td></tr><tr><td>Conc... |
f1b650a0a6dd53fed3185b32d2986c72452bc0e90816eab7ac1bcdcf3427259b.png | simple | <table><tr><td>Inner cortical width of thoracic pedicles (mm)</td><td>No. of thoracic pedicles instrumented</td><td>No. of thoracic pedicles accurately instrumented</td><td>Accuracy (%)</td></tr><tr><td>0–1.0</td><td>194</td><td>68</td><td>35.05</td></tr><tr><td>1.1–2.0</td><td>176</td><td>115</td><td>65.34... |
c138d794846e47a16f9e0ea365a72997c5b33c2f41b0f6a052584278b8cd2c5c.png | complex | <table><tr><td>EDA-Q items (18 items)</td><td>Corresponding DISCO items (17 items)</td><td>DISCO variables</td></tr><tr><td>Obsessively resists and avoids ordinary demands</td><td rowspan="2">Lack of co-operation</td><td rowspan="2">LACKCOP</td></tr><tr><td>Has difficulty complying unless carefully presented</td></tr><... |
ba22a43c753cba7e54a34236e8d015af726d8b12910198131acf09d22aecbf75.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">SA-test (reaction time (msec)</td></tr><tr><td>Active diet</td><td>Control diet</td></tr><tr><td>time 0</td><td>1320 ± 20</td><td>1320 ± 21</td></tr><tr><td>45 min</td><td>1219 ± 19</td><td>1230 ± 21</td></tr><tr><td>120 min</td><td>1182 ± 21</td... |
f3820f2ee720fd52b362186851f2b1452b5798e5f69e15830fd1a44ab312bce5.png | simple | <table><tr><td></td><td>Treatment-naïve cancer patients (<i>n</i>= 555)</td></tr><tr><td>Age, years (IQR)</td><td>62 (52-71)</td></tr><tr><td>Male gender, n (%)</td><td>227 (41%)</td></tr><tr><td>BMI kg/m<sup>2</sup>, (IQR)</td><td>25.0 (22.6–28.4)</td></tr><tr><td>Comorbidities</td><td></td></tr><tr><td> K... |
23b0492c3fd1436bde7529ebb613b31594f9670c786735d715d3392472908099.png | complex | <table><tr><td colspan="2">Time points of measurements</td><td>IOP</td><td>ONSD</td></tr><tr><td>T0</td><td>Patient awake in supine position before induction of anaesthesia</td><td>X</td><td>-</td></tr><tr><td>T1</td><td>20 min after induction of general anaesthesia in supine position</td><td>X</td><td>X</td></tr><tr><... |
715004b4f4b280be4b18c3c5261003354b1cfbe76d442cd180cc21cfe1a620fe.png | complex | <table><tr><td colspan="4"> </td></tr><tr><td colspan="4">Proteins present in all 8 <i>Mimiviridae </i>genomes</td></tr><tr><td>CLS10031</td><td>A1L transcription factor VLTF-2</td><td>CLS10052</td><td>Proliferating cell nuclear antigen</td></tr><tr><td>CLS10071</td><td>A2L transcription factor VLTF-3</td><td>CLS10035<... |
0d783210597fb784607f3e33aa4b07f3918ca778a84d4be9d7dd62635f840a3f.png | simple | <table><tr><td></td><td>MMSE Non-demented</td><td>MMSE Demented</td><td>EMSE Non-demented</td><td>EMSE Demented</td></tr><tr><td>Below 5<sup>th </sup>pcntle (MMSE cut-point = 21, EMSE cut-point = 41)</td><td>618 (3%)</td><td>622 (73%)</td><td>810 (5%)</td><td>474 (77%)</td></tr><tr><td>Below 10<sup>th </sup>pcntle (MMS... |
64cc095c38eb90e89372d8ff13b52d596ad4698e1be7645e2c16690ae1e370bf.png | complex | <table><tr><td>Trial centre</td><td>Trial arm</td><td colspan="3">Questionnaire type</td><td></td><td></td></tr><tr><td></td><td></td><td>Standard</td><td>Mini</td><td>Mini-mini</td><td>Total by study arm</td><td>Total by site</td></tr><tr><td>Bristol</td><td>Control (%)</td><td>54 (31)</td><td>6 (30)</td><td>9 (50)</t... |
1327cc5fd22984b1a156d27d172e7471703552904423bca3d8dc64370345a871.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="4">WAI</td></tr><tr><td>Status</td><td>Mean</td><td>S.D</td><td>P-value</td></tr><tr><td rowspan="2">Body mass index (kg/m<sup>2</sup>)</td><td>≥ 25 (n= 393)</td><td>41.65</td><td>6.72</td><td rowspan="2">0.031</td></tr><tr><td>< 25 (n= 283)</td><td>42.66</t... |
b1c749df95d37b99bd8ac9d9e25f9bdba1395582edf24d50d17ab6c1213f1d70.png | complex | <table><tr><td> </td><td colspan="2">Subchondral bone volume</td><td colspan="2">Subchondral bone migration area</td></tr><tr><td> </td><td>Pearson's <i>r</i></td><td><i>P</i> value</td><td>Pearson's <i>r</i></td><td><i>P</i> value</td></tr><tr><td>Weeks</td><td>0.799</td><td><0.001</td><td>0.799</td><td><0.001</... |
6dee634dd6e2a5006003855d935bd593cdc62f6857388534966677225868c690.png | complex | <table><tr><td>Country</td><td>Study type</td><td>Phase</td><td>n</td><td>Primary objective</td><td>Major findings</td></tr><tr><td rowspan="4">Thailand</td><td>HNV, PK and tolerability</td><td>1</td><td>24</td><td>PK and bio-availability of AS and MQ; administered separately and as a coformulation to healthy volunteer... |
4ce424d1896e7d94e80d7c326a6e50ddc8864a1f0064b508ee2670b0d599c9f1.png | simple | <table><tr><td>Outcome and complication</td><td>No. (%)</td></tr><tr><td>Mortality</td><td>6 (14.2%)</td></tr><tr><td>30 day</td><td>2 (4.8%)</td></tr><tr><td>1 year</td><td>1 (2.4%)</td></tr><tr><td>5 years</td><td>2 (4.8%)</td></tr><tr><td>Complications</td><td></td></tr><tr><td> Grade I</td><td>14 (33.3%)</td></tr><... |
74103fb49a6d7410c186459613c54c6d4e0178829a5c8939a7aae738037b7303.png | complex | <table><tr><td rowspan="2">Ordered by socioeconomic variable<sup>b</sup></td><td colspan="2">Male</td><td colspan="2">Female</td></tr><tr><td>Prevalence<sup>c</sup></td><td>Times/day<sup>d</sup></td><td>Prevalence<sup>c</sup></td><td>Times/day<sup>d</sup></td></tr><tr><td colspan="5">Based on ranges. <i>n</i> = 24<sup>... |
0c41e4fa7794a7506e5f8c9e70e9edd35ba73275411de0127291684d77ea6989.png | simple | <table><tr><td><i>Pollutant</i></td><td><i>Concentration</i></td><td><i>Averaging period</i></td><td><i>Permitted exceedences each year</i></td></tr><tr><td>Cuprum [μ/m<sup>3</sup>]</td><td>0,6 μg/m3</td><td>1 year</td><td>n/a</td></tr><tr><td>PM10</td><td>40 μg/m3</td><td>1 year</td><td>n/a</td></tr><tr... |
ccf5652e5b43fe461a3d0b198e55951bedaeda44440af9e0c72f95197d9b32fb.png | complex | <table><tr><td rowspan="2">Publication</td><td colspan="3">Zona pellucida breach</td><td rowspan="2">Embryonic stage</td><td rowspan="2">No of ET</td><td rowspan="2">Pregnancies conceived</td><td rowspan="2">Intervention</td><td rowspan="2">Outcome</td></tr><tr><td>ICSI</td><td>Assisted hatching</td><td>Embryo biopsy</... |
88bb5404cd6393fbc0bea4641ff296f7091384ad940a59cb1830d01cf23f5260.png | simple | <table><tr><td>Location and day</td><td>Central station</td><td>Adjacent to patient</td></tr><tr><td>John Radcliffe Hospital Adult ICU weekday</td><td>58.4 dB</td><td>59.7 dB</td></tr><tr><td>John Radcliffe Hospital Adult ICU weekend</td><td>59.1 dB</td><td>59.5 dB</td></tr><tr><td>Royal Berkshire Hospital ICU weekday<... |
7560d24b9499d1de6bbd5073753013ebac55492024eb9162afd80a2b83f71156.png | complex | <table><tr><td>Gene ID</td><td>Description</td><td>Lineage<sup>a</sup></td><td colspan="5"><i>dN/dS</i></td></tr><tr><td></td><td></td><td></td><td><i>A</i></td><td><i>B</i></td><td><i>C</i></td><td><i>D</i></td><td><i>E</i></td></tr><tr><td>YDR197W</td><td>Mitochondrial translational activator of the COB mRNA</td><td>... |
5fb8b154085fd44387ae5c8cf149d7dcbfeb8649032b91badb8cece30d739ab9.png | simple | <table><tr><td>Code</td><td>Before wetting</td><td>After wetting</td><td>Increased by</td></tr><tr><td>CH</td><td>220 μm</td><td>410 μm</td><td>46.34%</td></tr><tr><td>MCG</td><td>225 μm</td><td>310 μm</td><td>27.42%</td></tr><tr><td>F</td><td>240 μm</td><td>440 μm</td><td>45.45%</td></tr>... |
b1c3e28b1e044b59f0d88b1a7cb4d1b16a444f1a6a3043e88f69fcde2e1d5a55.png | complex | <table><tr><td>Vol.</td><td>Class</td><td>Macrogametocyte</td><td><i>k-1</i></td><td>Round stage</td><td><i>k-2</i></td><td>Ookinete</td><td><i>k-3</i></td><td>Oocyst</td><td><i>K</i></td></tr><tr><td></td><td colspan="9"><i>Anopheles dirus</i></td></tr><tr><td>11</td><td>HIGH</td><td>2978.0</td><td>*</td><td>3.23</td>... |
116220d2a69d768809cf40fc28e0a9760ba84905678c39ab39d5fd0ebedd91a4.png | complex | <table><tr><td></td><td colspan="3">Simulated Ontario Illness Attack Rates by the Percentage of Adults 53+ Years Old with Pre-existing Immunity<sup>1</sup></td><td></td><td colspan="2">Calibrated Attack Rates (AR)</td></tr><tr><td>Age</td><td>30%</td><td>50%</td><td>70%</td><td></td><td>Age</td><td>AR</td></tr><tr><td>... |
9bb2d30a5cbd35003d7c7d305a17dee2ad743daf665659f06d923842dc506d44.png | complex | <table><tr><td rowspan="2">Author</td><td rowspan="2" colspan="2">Sample size</td><td colspan="6">+936C/T</td><td colspan="6">−1154G/A</td></tr><tr><td>C</td><td>T</td><td>CC</td><td>CT</td><td>TT</td><td>HWE</td><td>G</td><td>A</td><td>GG</td><td>GA</td><td>AA</td><td>HWE</td></tr><tr><td rowspan="2">Rueda et al... |
bc7b9adde466f639cda77fb9a6d13c7d654ba98ad479dfa98438dd0d1e7afbaf.png | complex | <table><tr><td></td><td colspan="2">Child demographics</td><td colspan="2">Maternal psychopathology</td></tr><tr><td>Maternal Abuse Group</td><td>Age, M ± SD</td><td>Sex, % female</td><td>PTSD, M ± SD</td><td>Depression, M ± SD</td></tr><tr><td colspan="5">Physical Childhood Abuse</td></tr><tr><td> Low (... |
768bfd48789a6b686b203a90ff4d3ad1d5a61ec0293809ec3d5f841d2519881c.png | simple | <table><tr><td> </td><td>Enthalpy of desolvation, Δ<sub>desolv</sub>H (kJ mol<sup>−1</sup>) from DSC</td><td>Enthalpy of desolvation, Δ<sub>desolv</sub>H (kJ mol<sup>−1</sup>) calculated from equation 4</td></tr><tr><td>Atorvastatin (ATC)</td><td>-</td><td> </td></tr><tr><td>Solvate- I (ATC + 0.5 ... |
8a6842e0111ec4b676778aea6cb2dd348bd9f22a7095ca1f3b1232328656e088.png | simple | <table><tr><td>Behavioral trait</td><td></td></tr><tr><td>Time spent in predator channel (proportion)</td><td>0.44 ± 0.01<i>n </i>=<i> </i>11</td></tr><tr><td>Direct approaches toward predator (proportion)</td><td>0.32 ± 0.03<i>n </i>=<i> </i>11</td></tr><tr><td>Startle responses</td><td>0.52 ± 0.06<i>n ... |
6272f06cdacd946d4d2b1aba64498b5aed6ade0feceaca65b91a2138c8eca229.png | complex | <table><tr><td rowspan="3">Analyte</td><td colspan="3">FN<sup><i>a</i></sup></td><td colspan="3">FP</td></tr><tr><td rowspan="2">Original result (total)</td><td colspan="2">Discrepant investigation outcome<sup><i>b</i></sup></td><td rowspan="2">Original result (total)</td><td colspan="2">Discrepant investigation outcom... |
716065bf1be92c936546bdf9f77c9c70c1c9f99ba87363d83cea5fd9ec1041c2.png | simple | <table><tr><td>Clinical profile</td><td>Asthmatics (all subject)</td><td>AIA</td><td>ATA</td></tr><tr><td>N</td><td>592</td><td>163</td><td>429</td></tr><tr><td>Age of first medical examination (mean (range))</td><td>46.15 (15.40-77.88)</td><td>43.13 (17.22-72.73)</td><td>47.30 (15.40-77.88)</td></tr><tr><td>Height (cm... |
34d48a5eb44137023cb2ef858d29f0fb210fa9dd2b9f1b59269a2d0b7949d002.png | simple | <table><tr><td></td><td>Survivors(<i>n </i>= 45)</td><td>Nonsurvivors(<i>n </i>= 43)</td></tr><tr><td>Age (mean ± SD)</td><td>42 (35-50)</td><td>38 (29-46)</td></tr><tr><td>Male gender (%)</td><td>36 (80%)</td><td>31 (72%)</td></tr><tr><td>Location before ICU (ward, %)</td><td>24 (53%)</td><td>29 (67%)</td></tr><t... |
060e05d1801f9da92c0ef614657d4c88ea3c924a030495e7164ee86ede746aea.png | complex | <table><tr><td rowspan="2">Characteristics</td><td colspan="2">Correlation coefficient (<i>r</i>)</td><td colspan="2"><i>P</i> value</td></tr><tr><td>AA</td><td>SS</td><td>AA</td><td>SS </td></tr><tr><td>Age </td><td>−0.752</td><td>−0.744</td><td>0.000</td><td>0.000 </td></tr><tr><td>BMI</td><td>0.120</td><... |
5b09e71ab1b3acdbeb88b8fba4ab61f55b58615306ff86a8a712e4fc5ba9a662.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">β</td><td rowspan="2">SE</td><td colspan="2">Ventricular septal defects (yes vs. no)</td><td rowspan="2"><i>P </i>value</td></tr><tr><td>Odds ratio</td><td>95% confidence interval</td></tr><tr><td>NBL</td><td>−0.37</td><td>0.12</td><td>0.69</td><td>0.55... |
3246ab3bb41b1292beae95eff5ef2b00d2bb99c5adb54d10d2077f7177d4130e.png | simple | <table><tr><td> </td><td>RSV group A</td><td> </td><td>RSV group B</td><td> </td></tr><tr><td> </td><td>Global</td><td>Dadaab</td><td>Global</td><td>Dadaab</td></tr><tr><td>Period (years)</td><td>2006-11</td><td>2007-11</td><td>2006-11</td><td>2007-11</td></tr><tr><td>Total Sequences<sup>@</sup></td><td>649</td><td>182... |
2ed38b8d0a2c210238fac69baa0706fa4d6eb3c88b676e86e6169931ae73a69a.png | simple | <table><tr><td>Technique</td><td>N</td><td>TP</td><td>TN</td><td>FN</td><td>k</td><td>Sensitivity</td><td>Specify%</td><td>Specify%</td><td>PPV%</td><td>NPV%</td><td>Accuracy%</td></tr><tr><td>4D-TRAK</td><td>52</td><td>42</td><td>6</td><td>1</td><td>3</td><td>0.91</td><td>93.33</td><td>85.71</td><td>96.67</td><td>66.6... |
12e23151922c4536c672b61988940ec19010526d9ce7330be3bac99b81227d63.png | simple | <table><tr><td>Pupil size (mm)</td><td><i>n</i></td><td>Nurses’ estimations<sup>a</sup> (mm)</td><td>Pupillometer measurements<sup>a</sup> (mm)</td><td><i>P</i> value</td><td>Spearman's coefficient (95 % CI)</td><td><i>P</i> value</td></tr><tr><td><2</td><td>61</td><td>2 (2–2)</td><td>1.8 (1.6–1.8)... |
c052757abd67e1c2b4e4760b5c60f7c22cd1060c1a8c2dd8643b020c19e5155e.png | complex | <table><tr><td> </td><td> </td><td colspan="2">Full cohort</td><td colspan="2">Matched cohort</td></tr><tr><td> </td><td>Total<sup>a</sup></td><td>AKI<sup>a</sup></td><td>non-AKI<sup>a</sup></td><td>AKI<sup>a</sup></td><td>non-AKI<sup>a</sup></td></tr><tr><td>Clinical features</td><td>n = 1,030</td><td>n = 287</td><td>... |
bf583cbcca7e8ed677f3e7735f5c27da41741cebd7df3112698a38e2cd4a955e.png | simple | <table><tr><td> </td><td>n</td><td>Mean</td><td>Std. Deviation</td></tr><tr><td>FRACTURE STRENGTH</td><td>80</td><td>1016.6670</td><td>171.58485</td></tr></table> |
a70633dc191752fe6fac558181e10384ede42e4d6a0289429519d5931dff2006.png | simple | <table><tr><td></td><td>1997</td><td>2012</td></tr><tr><td>Subconjunctival hemorrhage</td><td>92 (28.75%)</td><td>133 (27.42%)</td></tr><tr><td>Conjunctivitis</td><td>108 (33.75%)</td><td>153 (31.75%)</td></tr><tr><td>Keratitis</td><td>20 (6.25%)</td><td>32 (6.60%)</td></tr><tr><td>Eyelid-related disorders</td><td>61 (... |
bf87c87cb054abf461f48851b791e5816abade45bae3be9ba4ffd00b2ca4d010.png | complex | <table><tr><td>Season</td><td>Entry<sup>∗</sup></td><td>Grain yield (t ha<sup>−1</sup>) (±SEM)</td><td>Number holes/plant (±SEM)</td><td>% Stem height tunnelled (±SEM)</td></tr><tr><td rowspan="3">1</td><td>Bt</td><td>6.4 ± 0.4ab</td><td>0.4 ± 0.3a</td><td>0.7 ± 0.3a</td></tr><... |
b224b6964e7c80743b2a44c608f03629fa026d01487651b0b9731137c32acbef.png | simple | <table><tr><td>Spot no.</td><td>Identity</td><td>MW (Da)</td><td>GenBank acc. no.</td><td>FC</td></tr><tr><td>1</td><td>Ser/Thr-specific protein phosphatase 2A A regulatory subunit β isoform (<i>Medicago sativa</i> subsp.×varia)</td><td>65161.6</td><td>AAG29594</td><td>0.647</td></tr><tr><td>2</td><td>Pyruvat... |
ab5712d4b3eac0ca0ff95682ab186855f5ffaeb6a49de17df8e54a32ff0c5d68.png | complex | <table><tr><td rowspan="3"></td><td colspan="10">Dorsal</td><td colspan="6">Ventral</td></tr><tr><td colspan="2">1 (pSN)</td><td colspan="2">2 (pSN)</td><td colspan="2">3 (aSN)</td><td colspan="2">4 (aSN)</td><td colspan="2">5 (aSN)</td><td colspan="2">A (pSN)</td><td colspan="2">B (pSN)</td><td colspan="2">C (aSN)</td... |
071fda764443bb874670d389db87d23ef3cd8731a6a51345d8ed9fca87f662ea.png | complex | <table><tr><td>Day</td><td colspan="3">Haematocrit</td><td colspan="3">Haemoglobin</td></tr><tr><td></td><td>Control</td><td>Group A</td><td>Group B</td><td>Control</td><td>Group A</td><td>Group B</td></tr><tr><td>0</td><td>28.3 ± 3.7</td><td>28.2 ± 3.7</td><td>28.4 ± 2.8</td><td>9.2 ± 1.3</td><td>9... |
f31df8bf2108472641ec086695c51635d48d540021874bf0f9c07fd91f9e674f.png | simple | <table><tr><td>Index</td><td>Segment</td><td><i>L</i></td><td><i>N</i><sub>opt</sub><sup>1</sup></td><td>Index</td><td>Segment</td><td><i>L</i></td><td><i>N</i><sub>opt</sub><sup>1</sup></td><td>Index</td><td>Segment</td><td><i>L</i></td><td><i>N</i><sub>opt</sub><sup>1</sup></td></tr><tr><td>1</td><td>B1 ↔ B2</t... |
101a34820961aab10677d06c00828f09a4d91595cc8575ec30ffd5728755f896.png | complex | <table><tr><td></td><td>CS-cineCMR</td><td>3D-HR-CMR(ref)</td><td>Diff</td><td rowspan="2">Diff [%]</td></tr><tr><td></td><td>Volume [ml]</td><td>Volume [ml]</td><td>Volume [ml]</td></tr><tr><td>Patient 1</td><td>62.5</td><td>59.0</td><td>3.5</td><td>5.7 %</td></tr><tr><td>Patient 2</td><td>61.5</td><td>71.0</td><td>&#... |
365f8c64ed6eb2fcd7acc21e68410c25a340ad17e6c630bba58e61d74b34dcf9.png | complex | <table><tr><td>Variable</td><td>Overall</td><td>0–5 years (<i>n</i> = 145)</td><td>6–10 years (<i>n</i> = 36)</td><td>11–15 years (<i>n</i> = 13)</td></tr><tr><td colspan="5">Weight-for-Height z-score</td></tr><tr><td>< −2 (%)</td><td>45 (31.5)</td><td>45 (31.5)</td><td>N/A</td><td>N/A</td></... |
92b8c850627b5762ab190972fb9f31f5b8783f3fb16802af6c5d91bd9d773b2f.png | complex | <table><tr><td>Study sites</td><td>Sampling units (classes of listed educational institutions below, wards of Village Development Committee (VDC<sup>a</sup> ))</td><td>Sampling unit population</td><td>Sample size (i.e. number of respondents)</td><td>Sample size (%)</td></tr><tr><td rowspan="2">Bachhayauli</td><td>Class... |
24ea1dee716ac99039a0c863237a7493156d3b0a4fd8eb076692f60227a1493f.png | complex | <table><tr><td></td><td>Women (<i>n</i> = 203)</td><td>Men (<i>n</i> = 161)</td><td>Overall (<i>N</i> = 364)</td></tr><tr><td colspan="4">Number (%) by age (years)</td></tr><tr><td> 25–44</td><td>90 (46.0)</td><td>76 (49.1)</td><td>16 (47.8)</td></tr><tr><td> 45–64</td><td>113 (54.0)</td><td>85 (50.9)</td><... |
81a3753d6c7acbf135b80f22467901f5a276f5ab53950f45441c6d5e290d5b74.png | complex | <table><tr><td></td><td>Referral hospitals</td><td>District hospitals</td><td>Health centers</td><td>Private clinics</td><td>Kigali</td><td>Other regions</td><td>All facilities/all regions</td></tr><tr><td>Average number of PAC cases per year per facility</td><td></td><td></td><td></td><td></td><td></td><td></td><td></... |
824f1ee999ce19d9e1b95683291fe1279cabde317ddfc1173db6190b9d4dfc95.png | complex | <table><tr><td>parameter</td><td>apo-Spr1654</td><td>Spr1654/PLP</td><td>Spr1654/PMP</td></tr><tr><td colspan="4">data collection statistics</td></tr><tr><td> resolution (Å) (range)</td><td>30.0–1.9 (2.0–1.9)</td><td>29.7–2.2 (2.3–2.2)</td><td>29.8–2.4 (2.5–2.4)</td></tr><tr><t... |
300cfd0333293461996b3d13432631ba644044a464b4237ef748cd3714ef42db.png | simple | <table><tr><td>First examiner</td><td>Hand</td><td>Thyroid </td><td>Eye lens</td><td>Chest</td><td>No. of Film</td><td>Exposure time (min)</td><td>X-ray tube location</td></tr><tr><td>Present study</td><td>27.0</td><td>5.0</td><td>3.0</td><td>6.0</td><td>2.5</td><td>2.4</td><td>Overcouch</td></tr><tr><td>Buls et al [14... |
6de3ed5fcd985b739042f36bf7bb4addfb7d8321aa33b6930f48cb12dd507516.png | simple | <table><tr><td>Population <i>n</i></td><td>Age (years)/avg ± SD range</td><td>Mass (kg)/Avg ± SD range</td><td>Stature (m)/Avg ± SDr ange</td><td>BMI/Avg ± SD range</td></tr><tr><td>10(<i>f</i> = 3, <i>m</i> = 7)</td><td>35.8 ± 8.822–53</td><td>53.6 ± 10.444–73</td><td>1.60 ... |
8997e7e41e1ce4c027f23cc9fd14c040aded4969e784c8f9e649cb638d164873.png | complex | <table><tr><td>Parameter</td><td>Pre-control</td><td>Post-control</td><td>Pre-transport</td><td>Post-transport</td></tr><tr><td colspan="5">Vital signs</td></tr><tr><td> Temperature (°C)</td><td>26.86 ± 0.06</td><td>26.35 ± 0.07</td><td>27.77 ± 0.06</td><td>25.63 ± 0.33</td></tr><tr><td> Heart ... |
76b71378bd995d486836fa5eb471a34c00f519bad2613277b4913a3a96f75de9.png | simple | <table><tr><td>Funcats</td><td>Number of genes assigned an InterAct class</td><td>Number of InterAct class 0000 genes</td><td><i>p</i>-value</td></tr><tr><td>All funcats</td><td>3,447</td><td>1,089</td><td>-</td></tr><tr><td>Metabolism</td><td>496</td><td>120</td><td>6.0 × 10<sup>-4</sup></td></tr><tr><td>Protein ... |
0cfcdcb5c398dc0448dcbffad50b0324964828dc0f244c6de50e6fa7368eac5e.png | simple | <table><tr><td>Factor</td><td>Coefficients</td><td>Standard error</td><td><i>t</i>-value</td><td><i>P</i> value</td></tr><tr><td>Intercept</td><td>−249.9</td><td>80.11</td><td>−3.120</td><td>0.02059</td></tr><tr><td>Yeast extract (L<sup>a</sup>)</td><td>41.53</td><td>12.19</td><td>3.405</td><td>0.01440</td>... |
4d936d699f2aba0c7da500af493b4ebcabeac968e77b8ee09ea4cb3d1db2d607.png | simple | <table><tr><td>Characteristics</td><td>No. of errors</td><td>%</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Male</td><td>860</td><td>64.5</td></tr><tr><td>Female</td><td>473</td><td>35.5</td></tr><tr><td>Total</td><td>1333</td><td>100</td></tr><tr><td>Age group</td><td></td><td></td></tr><tr><td>Less than... |
36022f86fb284ef6368d595e94780b9d55b3902550ddbc91b65fa27d3d336a21.png | simple | <table><tr><td>Drugs:</td><td>n</td><td>%</td></tr><tr><td>Adefovir</td><td>1</td><td>1.9</td></tr><tr><td>Boceprevir</td><td>1</td><td>1.9</td></tr><tr><td>Entecavir</td><td>9</td><td>17.3</td></tr><tr><td>Interferon</td><td>4</td><td>7.7</td></tr><tr><td>Pegylated interferon</td><td>9</td><td>17.3</td></tr><tr><td>La... |
2243e48084e8111ab5a1b03eabf9fe7ba4c4950aa3d3f6df4a0655d8d74fa9b9.png | simple | <table><tr><td>Liver</td><td>Total Modules</td><td>Counter-Intuitive Modules</td><td>% Total</td></tr><tr><td>1</td><td>88</td><td>20</td><td>22.73</td></tr><tr><td>2</td><td>143</td><td>52</td><td>36.36</td></tr><tr><td>3</td><td>147</td><td>67</td><td>45.58</td></tr><tr><td>4</td><td>117</td><td>41</td><td>35.04</td>... |
f5c5daeba7ba8e76ccf1efbe1669c23e01ff93a1fc46cbaced974c8ae0d48975.png | complex | <table><tr><td>Variables</td><td>Entire sample (100%)</td><td>Multiple sclerosis<sup>§ </sup>(46%)</td><td>Depressive disorders (32%)</td><td>Psychotic and other disorders (22%)*</td><td>Statistics (Pearson’s χ<sup>2 </sup>or ANOVA)</td></tr><tr><td>Gender, %</td><td> </td><td> </td><td> </td><td> </td>... |
c9755cfd3cec28b45c8d1df943f474f213b674c31e807ffabd3b30544a627c7f.png | complex | <table><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td colspan="2">IOP</td><td colspan="2">Visual acuity</td><td> </td></tr><tr><td>Patient code</td><td>Gender</td><td>Age Dx</td><td>Diagnosis</td><td>Gly326Ser</td><td>RE</td><td>LE</td><td>RE</td><td>LE</td><td>Surgical procedure</td></tr><tr><td>G62</td><td... |
76a44d87cf1f5b1b889f45595aee0fbe3ed034b53135109163ca02212251f0a6.png | simple | <table><tr><td></td><td></td><td>Single-Task</td><td>Dual-Task</td></tr><tr><td>200ms before and after HS<sup>a</sup></td><td>Frontal plane</td><td>0.9529±0.029</td><td>0.9270±0.044 *</td></tr><tr><td></td><td>Sagittal plane</td><td>0.9505±0.042</td><td>0.9373±0.046</td></tr><tr><td></td><td>Transve... |
de2319cafd9c7aafcf95ffa2e7814f72b84582e7b649e42d0c1be7f85486cbf3.png | simple | <table><tr><td>Test type</td><td>Dataset</td><td>Threshold</td><td><i>P</i>-value</td></tr><tr><td>Unpaired two sample</td><td>Aging—old vs. young</td><td>0.0537</td><td>0.0363</td></tr><tr><td></td><td></td><td>0.1074</td><td>0.0023</td></tr><tr><td></td><td></td><td>0.1609</td><td>8.45 × 10<sup>−4</s... |
62aba6bc56f411e715af9ba2c96307ec907d68e5d5507936a7bfc83fd79cc069.png | simple | <table><tr><td></td><td>cis-acting</td><td>trans-acting</td></tr><tr><td>KS p-value 10<sup>-6 </sup>- 10<sup>-15</sup></td><td>4,484</td><td>646</td></tr><tr><td>KS p-value 10<sup>-15 </sup>- 10<sup>-30</sup></td><td>5,311</td><td>500</td></tr></table> |
c3a5ae77f3ba11350a0a0dba63c857ff3d0d6329eb18df43f3d4b735d4c446e7.png | complex | <table><tr><td></td><td></td><td></td><td></td><td colspan="2">Correlation with BMI z-score<sup>1)</sup></td></tr><tr><td></td><td>Without MS</td><td>With MS</td><td><i>P</i><sup>2)</sup></td><td>WHO</td><td>CDC</td></tr><tr><td>Number of participants (%)</td><td>185 (75.2)</td><td>61 (24.8)</td><td>-</td><td>-</td><td... |
c8002461e107f08033f835e58fb34dbc5dec3dd9423a17aa64f2c480a1485b8c.png | complex | <table><tr><td rowspan="2">Parameter</td><td colspan="3">Correct</td></tr><tr><td>Study 1, No. (%)</td><td>Study, No. (%)</td><td>p</td></tr><tr><td>Registration of insertion date</td><td>337 (42.3)</td><td>339 (50.1)</td><td>0.003</td></tr><tr><td>Registration of daily surveillance</td><td>779 (97.7)</td><td>660 (98.2... |
0c2836b0e7327e9c84736e217cc592725d40536f9bb35234b36286451a9bcd61.png | simple | <table><tr><td>Characteristics</td><td>LGSOCNo. of patients (%)</td><td>HGSOCNo. of patients (%)</td><td><i>p</i> values</td></tr><tr><td>All cases</td><td>25</td><td>55</td><td></td></tr><tr><td>Mean Age, years (± SEM)</td><td>49.8 ± 3.0</td><td>56.8 ± 1.5</td><td>0.03</td></tr><tr><td>Type of primary s... |
5aff254d9ecb07b4e5332975c4cca3878ee7f9f25c1821f289fb9889fb1c17ac.png | simple | <table><tr><td></td><td>p-Nephrin</td><td>Nck (with p-Nephrin)</td><td>Nck (with p-TIR)</td><td>N-WASP</td></tr><tr><td>Null hypothesis</td><td>Single Exp.</td><td>Single Exp.</td><td>Single Exp.</td><td>Single Exp.</td></tr><tr><td>Alternate hypothesis</td><td>Double Exp.</td><td>Double Exp.</td><td>Double Exp.</td><t... |
a8777745e47e5deec535bc654e88708b0c372e324bb84e2e8148aeba68c551d3.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">2014</td><td colspan="2">2014+>2 HR</td><td colspan="2">2015</td><td colspan="2">2015+>2 HR</td></tr><tr><td>HR</td><td>VHR</td><td>HR</td><td>VHR</td><td>HR</td><td>VHR</td><td>HR</td><td>VHR</td></tr><tr><td>N</td><td>166</td><td>37</td><td>131</td><td>72</td><td>... |
f02a214f578e5fabe60e1e8cc824e16be02ae72c117e046a41f164119117b95b.png | complex | <table><tr><td>Day</td><td>Parameter</td><td>Reference<sup>§</sup></td><td>HFE mean</td><td>LFE mean</td><td><i>P</i>-value</td></tr><tr><td rowspan="9">0</td><td>Cholesterol (mg/dL) <sup>♦</sup></td><td>80–120</td><td>112.33 ± 20.6</td><td>122.22 ± 25.9</td><td>0.1904</td></tr><tr><td>Trigly... |
82a9dcf04c99efa68998838d3ea4764086043d96d94e5abffb4470daf51de26b.png | complex | <table><tr><td></td><td colspan="7">Talairach coordinates</td></tr><tr><td></td><td>Hemisphere</td><td>BA</td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td>Volume (mm<sup>3</sup>)</td><td>Mean <i>t</i></td></tr><tr><td colspan="8">REGION OF ACTIVATION</td></tr><tr><td>Medial frontal gyrus</td><td>Left/Right</t... |
373bd179cde589d235a1acc2d0bd4c3ca6869601b94cc55cf31f54a66362021e.png | complex | <table><tr><td rowspan="2">Variable</td><td>Rater</td><td colspan="2">Group activity</td><td>Control</td><td></td><td rowspan="2"><i>t</i></td><td rowspan="2">df</td><td rowspan="2"><i>p</i> (two-tailed)</td><td rowspan="2">Effect size</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td r... |
19cebeeb2bd32d32ded4a4e6ee831b4b71f561e287b449769d0c262d934f2ca5.png | simple | <table><tr><td>Protein</td><td>BQ00140 [49473701]</td><td>BQ00720 [49473755]</td><td>BQ03880 [49474026]</td><td>BQ12030 [49474691]</td><td>BQ07670 [49474353]</td><td>BQ11900 [49474679]</td></tr><tr><td>Length</td><td>222</td><td>83</td><td>198</td><td>91</td><td>336</td><td>172</td></tr><tr><td><i>Bra. jap</i>.</td><td... |
c6e09cc56bc17b01ad008df595ec5455672a2d489569ee7a4fe9400a09f4c90f.png | simple | <table><tr><td></td><td><i>B. subtilis</i></td><td><i>S. aureus</i></td><td><i>A. niger</i></td><td><i>S. cerevisiae</i></td></tr><tr><td><i>(a) Activity per full feces sample</i></td><td></td><td></td><td></td><td></td></tr><tr><td>Feces producer (FP)</td><td>P = 0.440</td><td>P = 0.098</td><td>P = 0.005</td><td>P <... |
9391e6b33f6c749d886e01a3beb9bfa0a2a1a19e1a3e3aef27a4cfed409c3dd6.png | simple | <table><tr><td>Disease stage</td><td>Number of patients</td><td>HU, IFN or combination pretreatment months from diagnosis median (range)</td><td>Months on imatinib median (range)</td><td>WBC x10<sup>9</sup>/L PB median (range) PLT x10<sup>9</sup>/L PB median (range)</td><td>Blasts in PB (%) median (range)</td><td>Ph+ c... |
3a258a73db7699eb473b3fc2aef096a2d7b061c50a0d87cca907dc9187f7fc33.png | complex | <table><tr><td rowspan="2">threshold</td><td colspan="4">Geuvadis data</td><td colspan="4">GenoExp data</td></tr><tr><td>Lasso</td><td>ENET</td><td>LMM</td><td>BSLMM</td><td>Lasso</td><td>ENET</td><td>LMM</td><td>BSLMM</td></tr><tr><td>0.05</td><td>2252</td><td>2262</td><td>2447</td><td>2567</td><td>1785</td><td>1414</... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.